Publications
Publications
Show Results For
- All HBS Web
(3,655)
- Faculty Publications (1,120)
- January 1994 (Revised April 1994)
- Case
EMC Corporation: Response to Shareholder Litigation (B)
By: Josh Lerner
Reports EMC's decision concerning the second shareholder class-action suit and its implications. Legislative efforts to reform securities litigation are also discussed. View Details
- December 1993 (Revised April 2006)
- Case
Marriott Corporation (A)
By: Lynn S. Paine and Charles A. Nichols
Marriott Corp.'s chairman and CEO must decide whether to recommend a restructuring of the company to the board of directors. The proposal he is considering would split the Marriott Corp., a premier hotel developer, owner, and manager, into two separate companies by a... View Details
- November 1993 (Revised September 1998)
- Supplement
Beech-Nut Nutrition Corporation (C): Conclusion
By: Lynn S. Paine
Describes the results of the charges related to the sale of the apple juice products. View Details
- September 1993 (Revised December 1993)
- Background Note
Note on Pricing and Public Policy
Surveys a number of essential issues related to pricing and public policy in market economies. Begins with a brief review of the price-determination process in competitive markets, then examines a range of topics involving pricing and public policy in monopoly and... View Details
- March 1993 (Revised June 1995)
- Case
Singapore TradeNet: The Tale Continues
By: Lynda M. Applegate, John L. King and Boon-Siong Neo
Continues the story of Singapore Network Services Pte. Ltd. (SNS), which was created to initiate and manage the creation of value-added networks for trade and other aspects of commerce in the island nation of Singapore. SNS built on its TradeNet experience to develop... View Details
- March 1993
- Supplement
Burroughs Wellcome and AZT (B)
Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details
- March 1993
- Supplement
Burroughs Wellcome and AZT (C)
Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details
- February 1993
- Supplement
Otis South Africa (C)
By: Michael Beer
Relates Otis South Africa's management actions in their efforts to transform the company. Students will be asked to judge the effectiveness of the corporate change programs instituted by management. View Details
- February 1993 (Revised August 1995)
- Case
Medicare Payment for Drugs and Medical Devices
- January 1993 (Revised April 1993)
- Case
Chadwick, Inc.: The Balanced Scorecard
By: Robert S. Kaplan
The pharmaceutical division of a diversified company has been asked to develop a Balanced Scorecard. Research and development projects take about ten years to bring a new product to the marketplace and the division depends on good relations and active feedback from its... View Details
- December 1992 (Revised September 1995)
- Exercise
Negotiation Exercise on Tradeable Pollution Allowances: General Background Information
Designed to teach students about the trade-offs faced by firms exploring alternative approaches to complying with pollution control regulations. The setting is the U.S. electric utility industry in 1993. In accordance with the provisions of the 1990 Clean Air Act,... View Details
- September 1992 (Revised October 1992)
- Case
Acid Rain: The Southern Co. (B)
In addition to the issues of expected cost minimization elucidated in Acid Rain: The Southern Co. (A), problems involving regulatory uncertainty are critical to the firm's Clean Air Act compliance strategy. The regulatory uncertainty affects, and is affected by, the... View Details
- May 1992 (Revised August 1993)
- Case
Forest Policy in Malaysia
The governments of Malaysia and the Malaysian State of Sarawak need to assess possible changes in forest policy. Environmentalist pressure threatens traditional market relationships and patterns of business-government interaction. Harvest regulations, subsidies, trade... View Details
- February 1992 (Revised October 1996)
- Case
CUC International, Inc. (A)
By: Krishna G. Palepu and Paul M. Healy
The case series examines the role of financial reporting and corporate finance policies as vehicles for communication between managers and outside investors. This case describes management's concern that the company's stock is undervalued because analysts viewed the... View Details
- February 1992 (Revised September 2019)
- Case
The House of Tata
By: James E. Austin and Ashish Nanda
The case traces the evolution of the Tata group, one of the largest and highly respected Indian business houses, from its 19th century founding and early growth in diverse industries, to its response to changes in government regulation in independent India, up to its... View Details
Keywords: Indian Economy; International Business; Government And Business; Government Regulation; Synergy; Conglomerates; Business Conglomerates; Developing Countries and Economies; Business and Government Relations; Business History; Steel Industry; Steel Industry; Steel Industry; Steel Industry; Steel Industry; India
- January 1992 (Revised April 1993)
- Case
FBO, Inc.
FBO, Inc. is a fixed-base operator at a large metropolitan airport. The general manager must decide if the current pooling format is the appropriate way to staff the commercial refueling operations. If pooling is deemed inappropriate then the implementation of a... View Details
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
- July 1991 (Revised August 1991)
- Case
Philip Morris Companies, Inc. (B)
Looks at the company's plans for a new debt offering under the Rule 415 shelf underwriting provision--in this instance from the vantage point of the lead investment banker for the deal. The decision-maker must assess the risks of the issuer, the tone of the market, the... View Details